SEC Form 4 reporting owner

Krognes Steve E.

Krognes Steve E. has filed 17 Form 4 transactions reported between December 31, 2025 and September 16, 2026, as Director of Guardant Health, Inc., Director of PLIANT THERAPEUTICS, INC. and Director of Denali Therapeutics Inc..

Name as filed: Krognes Steve E.

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$2.4M
5 lines
Companies
3
with Form 4 filings
Latest transaction
Sep 16, 2026
transaction date

Roles and reported holdings

  • GHGuardant Health, Inc.
    Dec 31, 2025 – Sep 16, 2026

    Director

    Held directly7,906 sh as of Sep 16, 2026 · Form 4

    24 months: $2.4M sold

  • PLRXPLIANT THERAPEUTICS, INC.
    Jun 11, 2026

    Director

    No common-stock holding reported on a purchase, sale, gift or withholding line.

  • DNLIDenali Therapeutics Inc.
    Jun 3, 2026

    Director

    No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 17 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 16, 2026GHDirectorOpen-market saleCode S · direct971$172K@ $177.48Form 4
Sep 16, 2026GHDirectorOpen-market saleCode S · direct1,300$229K@ $176.34Form 4
Sep 16, 2026GHDirectorOpen-market saleCode S · direct3,300$579K@ $175.42Form 4
Sep 16, 2026GHDirectorOpen-market saleCode S · direct1,103$192K@ $174.46Form 4
Jun 30, 2026GHDirectorOption exerciseCode M · direct155—Form 4
Jun 17, 2026GHDirectorGrant or awardCode A · direct2,711—Form 4
Jun 17, 2026GHDirectorOption exerciseCode M · direct4,203—Form 4
Jun 11, 2026PLRXDirectorGrant or awardCode A · direct70,000—Form 4
Jun 4, 2026GHDirectorOpen-market saleCode S · direct9,294$1.2M@ $132.51Form 4
Jun 3, 2026DNLIDirectorGrant or awardCode A · direct19,226—Form 4
Jun 3, 2026DNLIDirectorGrant or awardCode A · direct6,408—Form 4
May 31, 2026GHDirectorOption exerciseCode M · direct154—Form 4
Apr 30, 2026GHDirectorOption exerciseCode M · direct154—Form 4
Mar 31, 2026GHDirectorOption exerciseCode M · direct155—Form 4
Feb 28, 2026GHDirectorOption exerciseCode M · direct154—Form 4
Jan 31, 2026GHDirectorOption exerciseCode M · direct154—Form 4
Dec 31, 2025GHDirectorOption exerciseCode M · direct154—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.